120 related articles for article (PubMed ID: 2311669)
1. Local cutaneous hemodynamic effects of carvedilol and labetalol in the anesthetized rat.
Willette RN; Sauermelch CF; Ruffolo RR
Eur J Pharmacol; 1990 Feb; 176(2):237-40. PubMed ID: 2311669
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic differences between carvedilol and labetalol in the cutaneous circulation.
Ruffolo RR; Sauermelch CF; Willette RN
Eur J Clin Pharmacol; 1990; 38 Suppl 2():S112-4. PubMed ID: 1974499
[TBL] [Abstract][Full Text] [Related]
3. The dose dependency of the alpha- and beta-adrenoceptor antagonist activity of carvedilol in man.
Tham TC; Guy S; McDermott BJ; Shanks RG; Riddell JG
Br J Clin Pharmacol; 1995 Jul; 40(1):19-23. PubMed ID: 8527263
[TBL] [Abstract][Full Text] [Related]
4. Effect of carvedilol on renal hemodynamics and renal excretory function in spontaneously hypertensive rats.
Gellai M; DeWolf R; Ruffolo RR
Pharmacology; 1990; 41(4):200-6. PubMed ID: 2080230
[TBL] [Abstract][Full Text] [Related]
5. Vasodilating mechanism and response to physiological pressor stimuli of acute doses of carvedilol compared with labetalol, propranolol and hydralazine.
Tomlinson B; Bompart F; Graham BR; Liu JB; Prichard BN
Drugs; 1988; 36 Suppl 6():37-47. PubMed ID: 2908303
[TBL] [Abstract][Full Text] [Related]
6. Influences of carvedilol treatment on the effects of acetylcholine on regional haemodynamics in the spontaneously hypertensive rat.
Granstam SO; Fellström B; Lind L
Clin Sci (Lond); 1998 Sep; 95(3):303-9. PubMed ID: 9730849
[TBL] [Abstract][Full Text] [Related]
7. Haemodynamics of carvedilol in normal subjects compared with propranolol, pindolol, and labetalol.
Tomlinson B; Cronin CJ; Graham BR; Prichard BN
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S69-75. PubMed ID: 2454372
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the mechanism underlying the vasodilator action of carvedilol in pithed spontaneously hypertensive rats.
Hashimoto H; Tanaka M; Kanda A; Akashi A
Drugs; 1988; 36 Suppl 6():31-6. PubMed ID: 2908302
[TBL] [Abstract][Full Text] [Related]
9. Features of the acute hypotensive action of carvedilol and its ameliorating effect on myocardial ischemia.
Hashimoto H; Kanda A; Hubo H; Tanaka M
J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S22-8. PubMed ID: 1721975
[TBL] [Abstract][Full Text] [Related]
10. Vasodilatory action of carvedilol.
Sponer G; Strein K; Bartsch W; Müller-Beckmann B
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S5-11. PubMed ID: 1378150
[TBL] [Abstract][Full Text] [Related]
11. Studies on the mode of vasodilating action of carvedilol.
Sponer G; Strein K; Müller-Beckmann B; Bartsch W
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S42-8. PubMed ID: 2454366
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of the vasodilatory effect of carvedilol in normal volunteers: a comparison with labetalol.
Cubeddu LX; Fuenmayor N; Varin F; Villagra VG; Colindres RE; Powell JR
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S81-4. PubMed ID: 2454374
[TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacology of carvedilol in normal volunteers.
Cubeddu LX; Fuenmayor N; Varin F; Villagra VG; Colindres RE; Powell JR
Clin Pharmacol Ther; 1987 Jan; 41(1):31-44. PubMed ID: 3802704
[TBL] [Abstract][Full Text] [Related]
14. Effect of carvedilol on venous return: a mechanism of reduction in blood pressure.
Ishibashi T; Okuhira M; Hamaguchi M; Katsumata N; Nakazawa M; Imai S
Jpn J Pharmacol; 1991 Jan; 55(1):186-9. PubMed ID: 1674971
[TBL] [Abstract][Full Text] [Related]
15. Carvedilol and lacidipine prevent cardiac hypertrophy and endothelin-1 gene overexpression after aortic banding.
Massart PE; Donckier J; Kyselovic J; Godfraind T; Heyndrickx GR; Wibo M
Hypertension; 1999 Dec; 34(6):1197-201. PubMed ID: 10601118
[TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacology of carvedilol.
Tomlinson B; Prichard BN; Graham BR; Walden RJ
Clin Investig; 1992; 70 Suppl 1():S27-36. PubMed ID: 1350481
[TBL] [Abstract][Full Text] [Related]
17. Role of beta 2-receptor stimulation in the peripheral vascular actions of the antihypertensive dilevalol.
Watkins RW; Sybertz EJ; Cook J; Pula K; Cedeno K; Tedesco RP; McLeod R
Arch Int Pharmacodyn Ther; 1989; 302():158-73. PubMed ID: 2576892
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of carvedilol and metoprolol on regional vascular responses to adrenergic stimuli in normal subjects and patients with chronic heart failure.
Hryniewicz K; Androne AS; Hudaihed A; Katz SD
Circulation; 2003 Aug; 108(8):971-6. PubMed ID: 12912816
[TBL] [Abstract][Full Text] [Related]
19. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
Wong GW; Laugerotte A; Wright JM
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
[TBL] [Abstract][Full Text] [Related]
20. Effects of carvedilol, losartan and trimetazidin on functional parameters of isolated heart of rats at oxidative stress.
Antelava N; Gabunia L; Gambashidze K; Petriashvili Sh; Bejitashvili N
Georgian Med News; 2009 Feb; (167):81-4. PubMed ID: 19276478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
